PDGFRB and cancer: As activated PDGF-R signaling pathway in tumor stroma can increase the proliferation of cancer cells [57] and stimulate GC angiogenesis [61], nilotinib could be used as a potential inhibitor for GCs with a profuse fibrotic stroma [51].